Question 1

What is the catalog number for CD150 (Y307) (Signaling Lymphocytic Activation Molecule, IPO-3, CDw150, SLAMF1, SLAM) (MaxLight 405) discontinued?

Accepted Answer

The catalog number for CD150 (Y307) (Signaling Lymphocytic Activation Molecule, IPO-3, CDw150, SLAMF1, SLAM) (MaxLight 405) discontinued is C2548-81Y-ML405.

Question 2

What sizes are available for CD150 (Y307) (Signaling Lymphocytic Activation Molecule, IPO-3, CDw150, SLAMF1, SLAM) (MaxLight 405) discontinued?

Accepted Answer

CD150 (Y307) (Signaling Lymphocytic Activation Molecule, IPO-3, CDw150, SLAMF1, SLAM) (MaxLight 405) discontinued is available in the following size(s): 100 µL.

Question 3

Is CD150 (Y307) (Signaling Lymphocytic Activation Molecule, IPO-3, CDw150, SLAMF1, SLAM) (MaxLight 405) discontinued in stock?

Accepted Answer

CD150 (Y307) (Signaling Lymphocytic Activation Molecule, IPO-3, CDw150, SLAMF1, SLAM) (MaxLight 405) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 5

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

CD150 (Y307) (Signaling Lymphocytic Activation Molecule, IPO-3, CDw150, SLAMF1, SLAM) (MaxLight 405) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

CD20 (B9E9), CF568 conjugate, 0.1mg/mL

CD46 (122.2), CF740 conjugate, 0.1mg/mL

CD86 (BU63), CF640R conjugate, 0.1mg/mL

CD5 (Cris-1), CF640R conjugate, 0.1mg/mL

CD54 / ICAM-1 (15.2), CF640R conjugate, 0.1mg/mL

BMI1 (Oncogene and Stem Cell Marker) (BMI1/2823), CF640R conjugate, 0.1mg/mL